BIO Urges FDA To Maintain Its Independence For COVID-19 Decisions

By Beth Wang / September 3, 2020 at 6:53 PM
In an open letter published Thursday (Sept. 3) , the Biotechnology Innovation Organization urges FDA to maintain its independence as the “gold-standard” regulatory body, and for politics to stay out of the development and approval of new medicines so the public can rest assured any vaccine or therapy that comes to market has undergone a rigorous review process and has been upheld to the “highest standards of scientific and medical integrity.” The organization also calls for companies to make sure...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.